Followers | 199 |
Posts | 21795 |
Boards Moderated | 2 |
Alias Born | 11/07/2005 |
Tuesday, October 31, 2017 10:10:57 AM
“Our Cryogenic process appears to trigger the production of Adult Stem Cells, based on independent research on the Endocannabinoid system and the entourage effect,” said Steve Kubby, CEO and President of Kubby Cryogenics. According to a recent peer reviewed study, the endocannabinoid system directs cell fate specification of Neural Stem Cells in the Central Nervous System, which can lead to new cell generation in the brain and the periphery systems.
https://www.ncbi.nlm.nih.gov/pubmed/24076098
Kubby Cryogenics manufacturing division produces a unique biomedicine from the raw cannabis plant. This new class of medicine is the company’s own proprietary method capturing the vitality of the raw plant in its extraction process.
This small batch, apothecary approach captures the live resins that have medical benefits for a number of ailments, including: cancer, inflammatory disease, epilepsy, brain injury, autism, Alzheimer’s, and more.
Float only 1.6 million shares
very few shares on ask
http://quotes.freerealtime.com/dl/frt/M?IM=quotes&type=Quote&symbol=idvv
IDVV
Have a great low float, or killer chart to share with our group of traders?
Post it up on my new board!
Sweet Crude's - Low Float and Chart Plays (please join)
http://investorshub.advfn.com/boards/board.aspx?board_id=21852
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM